Zygomatic versus conventional dental implants in augmented maxillae: a pragmatic multicenter randomised clinical trial

Dr Gunaseelan Rajan0 个研究点目标入组 180 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Patients with fully edentulous and atrophic maxilla not having sufficient bone volumes for placing dental implants at all or when it is possible to place only 2 implants in the front area (minimal diameter 3.5 mm and length of 8 mm) as evaluated on TC scans.
•No more than 4 mm of bone height should be available subantrally.

•General contraindications to implant surgery such as
•Patient irradiated in the head and neck region with greater than 70 Gray. Immunosuppressed or immunocompromised patients. Patients who took or are taking amino-bisphosphonates intravenously. Patients with poor oral hygiene and motivation. Patients with untreated periodontitis. Uncontrolled diabetes. Pregnancy or lactation. Addiction to alcohol or drugs. Psychiatric problems. Lack of opposite occluding dentition or prosthesis. Restricted mouth opening of less than 3.5 cm inter-arch anteriorly. Patients with an acute or chronic infection or inflammation in the area intended for implant placement. Patient unable to commit to 15 year follow-up. Patients participating in other investigations if the present protocol cannot be properly adhered to. Patients referred only for implant placement.

发起方

Dr Gunaseelan Rajan